Core Nursing Explanation
Key Concept Analysis: This question assesses the nurse's ability to identify a
life-threatening adverse effect of benzodiazepine therapy (lorazepam) used for
Alcohol Withdrawal Syndrome (AWS). The core principle is
Key Point! Airway, Breathing, Circulation (ABC) priority. While managing AWS symptoms like agitation and preventing seizures is crucial, the nurse's primary responsibility is to monitor for and respond to the most dangerous complication of the treatment itself:
respiratory depression.
Answer Rationale: Option ②, "Respiratory rate of 8 breaths per minute with shallow breathing," is the correct answer. A respiratory rate of
8 breaths/min (normal adult range:
12-20 breaths/min) with shallow effort indicates significant
central nervous system (CNS) depression. Lorazepam, a benzodiazepine, potentiates the effect of the inhibitory neurotransmitter GABA, which can suppress the brainstem's respiratory drive. This is a medical emergency that can rapidly lead to hypoxia, respiratory arrest, and death, requiring immediate intervention such as administering the reversal agent
flumazenil (in specific situations), providing respiratory support, and notifying the provider.
Distractor Analysis:
Watch out for confusion! Option ①: Mild nausea and anorexia are common in AWS and during early recovery. They require monitoring and supportive care (e.g., antiemetics, small frequent meals) but are not immediately life-threatening.
Option ③: Drowsiness that resolves with verbal stimulation is a common and expected sedative effect of benzodiazepines. It indicates the medication is working to control agitation and anxiety. The nurse should continue to monitor for progression to deeper sedation but does not require immediate action for this finding alone.
Option ④: A blood pressure of
140/90 mmHg with tremors are classic signs of
autonomic hyperactivity seen in AWS (part of the Clinical Institute Withdrawal Assessment for Alcohol, revised (CIWA-Ar) scale). This finding indicates that the patient may need
more medication (lorazepam) to control withdrawal symptoms, not that the current medication dose is causing an emergency. The priority is the opposite problem—over-sedation leading to respiratory compromise.
Related Concepts: This scenario highlights the delicate balance in managing AWS: administering enough benzodiazepine to prevent dangerous withdrawal complications (seizures, delirium tremens) while vigilantly avoiding oversedation. Nursing assessment must continuously evaluate both the severity of withdrawal (using tools like CIWA-Ar) and the patient's response to therapy, with respiratory status being the paramount safety check.
Concept Summary
| Concept | Key Points |
|---|
| Alcohol Withdrawal Syndrome (AWS) | Autonomic hyperactivity (tachycardia, hypertension, tremor), agitation, risk of seizures and Delirium Tremens (DTs). Managed with benzodiazepines (lorazepam, diazepam). |
| Benzodiazepine (Lorazepam) Action | Enhances GABA, causing sedation, anxiolysis, muscle relaxation. Primary risk: Dose-related CNS & respiratory depression. |
| Nursing Priority (ABCs) | Airway and Breathing are always top priority. Respiratory depression is an immediate life threat. |
| CIWA-Ar Scale | Tool to objectively assess AWS severity and guide medication dosing. Assesses nausea, tremor, sweating, anxiety, etc. |
Side-by-Side Comparison!
| Assessment Finding | Likely Cause & Implication | Required Nursing Action |
|---|
| Respiratory Rate 8/min, Shallow | Key Point! Benzodiazepine Toxicity/Over-sedation. Life-threatening respiratory depression. | IMMEDIATE INTERVENTION. Stimulate patient, prepare for airway support, administer reversal agent per protocol, notify provider stat. |
| BP 140/90, Tremors, Agitated | Inadequate AWS control. Patient is still in active withdrawal. Risk of progression to seizures/DTs. | Re-assess using CIWA-Ar, administer next scheduled or PRN dose of benzodiazepine as ordered, provide calm environment. |
| Drowsy but easily aroused | Therapeutic medication effect. Desired outcome for anxiety and agitation control. | Continue monitoring. Reassess sedation level frequently (e.g., every 1-2 hours). Ensure patient safety (side rails up, call bell within reach). |
Anatomy, Physiology & Pharmacology Points
- Pathophysiology: Chronic alcohol use depresses the CNS. Abrupt cessation leads to a rebound hyperexcitable state (AWS) due to unopposed glutamate (excitatory) activity.
- Drug Mechanism: Lorazepam binds to GABA-A receptors, increasing chloride ion influx into neurons, causing hyperpolarization (inhibition) and counteracting AWS hyperactivity.
- Critical Site: The medulla oblongata in the brainstem contains the respiratory center. Excessive CNS depression from benzodiazepines can suppress this center's drive to breathe.
Memory Tips
- ABCs for AWS: Always Check Breathing Before giving more Benzos. The biggest danger from the treatment is stopping Breathing.
- CIWA-Ar vs. Sedation: Think of two scales you're constantly balancing: one for Withdrawal (needs more drug) and one for Sedation (has too much drug). Respiratory rate is your clearest sign the sedation scale is tipping dangerously.
High-Frequency NCLEX Topics
NCLEX loves testing
priority-setting and
adverse drug reactions. Benzodiazepine-induced respiratory depression is a classic. You will also be tested on recognizing signs of
inadequate vs.
excessive treatment for AWS. Remember: Agitation/tremors = likely needs meds. Slow/shallow breathing = likely has too much meds.
Watch Out for Question Variations!
- Instead of "most concerning finding," the question may ask: "The nurse's priority action is to:" (Answer: Assess airway/breathing and prepare to administer naloxone/flumazenil? – Note: Flumazenil is for benzo reversal, but use is controversial in AWS due to seizure risk).
- The scenario could shift to opioid overdose mixed with AWS, testing recognition of pinpoint pupils and the use of naloxone.
- It may ask you to identify which patient is most at risk for respiratory depression (e.g., elderly patient, those with COPD or sleep apnea, or patients on concurrent opioids).